Tom Henley

Tom Henley

Company: Intima Bioscience

Job title: CSO


Utilizing Multiplex CRISPR Gene Editing to Assess New Classes of Intra Cellular Immune Checkpoint Molecules for Application in TIL 12:00 pm

• Comparing the function of CISH deletion relative to both extracellular and intracellular immune checkpoints in neoantigen cytolysis models • Demonstrating intra-cellular immune checkpoint protein CISH can potentially enhance anti-tumor responses against a broad range of cancer types regardless of PD-L1 biomarker status • Considering next generation checkpoints and the application to TILRead more

day: Day Two

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.